Literature DB >> 18080567

[Study on the genotype of Mycobacterium tuberculosis isolates from hospitals in Tianjin].

Li-Quan Chai1, Wei-Min Li, Li Li, Zong-Jia Dai, Da-Peng Bai, Li Zhang, Shi-Feng Shao, Qi Wu, Wei Lu, Zhao-Gang Sun, Chuan-Yuo Li.   

Abstract

OBJECTIVE: To explore the characteristics on molecular epidemiology of Mycobacterium tuberculosis isolates from hospitals in Tianjin area.
METHODS: One hundred M. tuberculosis isolated strains were collected in succession from August 16th-December 25th, 2005 in Tianjin Haihe Hospital and genotyped by spoligotyping and multiple locus variable number-tandem repeat(VNTR). Data was analyzed by cluster software. Based on the concept of Beijing lineage, it was determinate two sub-groups: atypical Beijing strains and W strain/typical family strains by multiplex and real-time PCR. The associations of subgroups with drug resistance and age were assessed by the chi2 test.
RESULTS: 96 M. tuberculosis strains were genotyped in which 91.7% (88/96) strains belonged to Beijing genotype (including 3 Beijing-like strains) by spoligtyping. VNTR typing could differentiate 60 genotypes among the 88 Beijing genotype strains. 93.2% of the Beijing lineage M. tuberculosis strains of this study belonged to W strain/typical Beijing family strains (82/88). No statistically significant differences were observed in the proportions of the two sub-groups in patients of different age, or drug resistance (P > 0.05).
CONCLUSION: The M. tuberculosis Beijing genotype strains were dominated on tuberculosis hospital patients of Tianjin area. The discriminatory power of VNTR typing was higher than that of spoligtyping. The two sub-groups of Beijing lineage had been prevalent in Tianjin, however W strain/typical Beijing family strains were of preponderance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080567

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

1.  Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China.

Authors:  Juan Wang; Yan Liu; Chun-Lei Zhang; Bin-Ying Ji; Liu-Zhuo Zhang; Yong-Zhen Shao; Shui-Lian Jiang; Yasuhiko Suzuki; Chie Nakajima; Chang-Long Fan; Yuan-Ping Ma; Geng-Wen Tian; Toshio Hattori; Hong Ling
Journal:  J Clin Microbiol       Date:  2011-02-16       Impact factor: 5.948

2.  Non-Beijing strains of Mycobacterium tuberculosis in China.

Authors:  Xia Li; Peng Xu; Xin Shen; Lihong Qi; Kathryn DeRiemer; Jian Mei; Qian Gao
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

3.  Genetic diversity of Mycobacterium tuberculosis isolates from Tibetans in Tibet, China.

Authors:  Haiyan Dong; Li Shi; Xiuqin Zhao; Ba Sang; Bing Lv; Zhiguang Liu; Kanglin Wan
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

4.  Genetic diversity of Mycobacterium tuberculosis isolates from Inner Mongolia, China.

Authors:  Qin Yu; Yunkai Su; Bing Lu; Yan Ma; Xiuqin Zhao; Xiaomin Yang; Haiyan Dong; Yao Liu; Lulu Lian; Li Wan; Yimou Wu; Kanglin Wan
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

5.  Role of MIRU-VNTR and spoligotyping in assessing the genetic diversity of Mycobacterium tuberculosis in Henan Province, China.

Authors:  Jie Shi; Danwei Zheng; Yankun Zhu; Xiaoguang Ma; Shaohua Wang; Hui Li; Jin Xing
Journal:  BMC Infect Dis       Date:  2018-09-03       Impact factor: 3.090

6.  First insight into the genotypic diversity of clinical Mycobacterium tuberculosis isolates from Gansu Province, China.

Authors:  Jie Liu; Chongxiang Tong; Jiao Liu; Yuan Jiang; Xiuqin Zhao; Yuanyuan Zhang; Haican Liu; Bing Lu; Kanglin Wan
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

7.  Characterization of Mycobacterium tuberculosis isolates from Hebei, China: genotypes and drug susceptibility phenotypes.

Authors:  Yanan Li; Xinrui Cao; Shiming Li; Hao Wang; Jianlin Wei; Peng Liu; Jing Wang; Zhi Zhang; Huixia Gao; Machao Li; Kanglin Wan; Erhei Dai
Journal:  BMC Infect Dis       Date:  2016-03-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.